These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9372900)

  • 1. MUSE therapy: preliminary clinical observations.
    Werthman P; Rajfer J
    Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
    Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
    N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.
    Sexton WJ; Benedict JF; Jarow JP
    J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
    Amar E
    Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
    Bodner DR; Haas CA; Krueger B; Seftel AD
    Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
    Raina R; Pahlajani G; Agarwal A; Zippe CD
    BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
    Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
    J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
    Pangkahila WI
    Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
    Linet OI; Ogrinc FG
    N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
    Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
    J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
    Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
    Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.
    Benevides MD; Carson CC
    J Urol; 2000 Mar; 163(3):785-7. PubMed ID: 10687977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Porst H
    Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Ulster Med J; 1994 Apr; 63(1):18-22. PubMed ID: 8658990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 in the therapy of erectile deficiency.
    Beretta G; Zanollo A; Ascani L; Re B
    Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.